Features
Killing the Goose That Laid the Golden Egg
A troubling trend is apparent in medical malpractice actions venued in New Jersey: Over the past few decades, our courts have undermined legislation meant to limit hospital liability for tort claims.
Features
Attacking the Electronic Medical Record
The electronic age has paved the way for speedy retrieval of medical records. But the problem is that the electronic record is only as good as the individuals who input the information into the record itself.
Features
Unconventional Lawyering Leading to Conventional Credibility
The authors contend that there are many real-life examples of out-of-the-box methods that attorneys can adapt and employ at trial, and indeed throughout the development of their case. Here are some examples of unconventional lawyering that work very well, they say.
Features
Recording Surgery
Recently, the topic of audiovisual recording of surgical procedures is coming up in the national conversation. What might the consequences of this newer trend be?
Columns & Departments
Verdicts
Is the MCARE Act applicable to expert testimony when a nurse, not a physician, is a defendant? A Pennsylvania court says no.
Features
<b><i>Ptaszsynski v. Atlantic Health Sys</i></b>.
The New Jersey Appellate Division's opinion in <I>Ptaszynski v. Atlantic Health Sys. Inc.</I> will impact not only New Jersey nursing home litigation, but also that state's medical malpractice litigation in general. Here's why.
Columns & Departments
Drug & Device News
Suits involving Risperdal and Cymbalta are discussed.
Telemedicine: Best Practices to Avoid Liability
Telemedicine is rapidly evolving, and with its evolution comes new potential pitfalls and risks. Practitioners in this area should keep abreast of state laws and regulations regarding telemedicine, as well as keep an eye out for developments in the federal landscape.
Features
Navigating Insurance Coverage Issues in Med Mal Litigation
In last month's newsletter, we saw that insurance problems may lurk in the shadows, even for those medical professionals and entities that think they are fully covered. We continue the discussion of "insurance traps" here.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- The DOJ's Corporate Enforcement Policy: One Year LaterThe DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.Read More ›
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›
- The Roadmap of Litigation AnalyticsLitigation analytics can be considered a roadmap of sorts — an important guide to ensure the legal professional arrives at the correct litigation strategy or business plan. However, like roadmaps, litigation analytics will only be useful if it's based on data that is complete and accurate.Read More ›
- The DOJ's New Parameters for Evaluating Corporate Compliance ProgramsThe parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.Read More ›
- Understanding the Potential Pitfalls Arising From Participation in Standards BodiesChances are that if your company is involved in research and development of new technology there is a standards setting organization exploring the potential standardization of such technology. While there are clear benefits to participation in standards organizations — keeping abreast of industry developments, targeting product development toward standard compliant products, steering research and intellectual property protection into potential areas of future standardization — such participation does not come without certain risks. Whether you are in-house counsel or outside counsel, you may be called upon to advise participants in standard-setting bodies about intellectual property issues or to participate yourself. You may also be asked to review patent policy of the standard-setting body that sets forth the disclosure and notification requirements with respect to patents for that organization. Here are some potential patent pitfalls that can catch the unwary off-guard.Read More ›
